The leading aim was to detect suited analytical targets by examining human hepatocyte incubation samples with high-resolution mass spectrometry (HRMS) and to confirm the outcomes in reliable urine specimens and to ascertain AB-FUBINACA's metabolic security in human liver microsomes and as opposed hepatocyte and urine success with in silico predicti